Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aim Immunotech Inc (NY: AIM )

0.4579 -0.0221 (-4.60%)
Streaming Delayed Price Updated: 1:19 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,785
Open 0.4900
Bid (Size) 0.4550 (15)
Ask (Size) 0.4580 (3)
Prev. Close 0.4800
Today's Range 0.4500 - 0.4999
52wk Range 0.3201 - 0.7487
Shares Outstanding 4,020,334
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For April 2, 2024
Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter. 
Via Benzinga

Performance

YTD
-3.60%
-3.60%
1 Month
+22.11%
+22.11%
3 Month
+6.49%
+6.49%
6 Month
-8.42%
-8.42%
1 Year
-11.94%
-11.94%

More News

Read More
Preview: AIM ImmunoTech's Earnings
Via Benzinga
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Preview: AIM ImmunoTech's Earnings
Via Benzinga
Earnings Outlook For AIM ImmunoTech
Via Benzinga
Earnings Scheduled For March 26, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid
From AIM ImmunoTech Inc.
Via Business Wire
AIM ImmunoTech Provides Update Regarding Annual Meeting
From AIM ImmunoTech Inc.
Via Business Wire
AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
From AIM ImmunoTech Inc.
Via Business Wire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today?
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
From AIM ImmunoTech Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Earnings Scheduled For August 11, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.